{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:52:06Z","timestamp":1787730726324,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,17]]},"DOI":"10.7759\/cureus.69571","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T20:08:32Z","timestamp":1726603712000},"source":"Crossref","is-referenced-by-count":2,"title":["Demographic, Clinical, and Surgical Risk Factors of Pars Plana Vitrectomy (PPV) for Neovascular Glaucoma (NVG) Development in Type 2 Diabetes Mellitus Patients"],"prefix":"10.7759","author":[{"given":"Faruk","family":"Nisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Lepara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijad","family":"Jahi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edin","family":"Begi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Alic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almir","family":"Fajki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.134","article-title":"Is day-1 postoperative review necessary after pars plana vitrectomy?","volume":"29","author":"Alexander P","year":"2015","unstructured":"Alexander P, Michaels L, Newsom R. Is day-1 postoperative review necessary after pars plana vitrectomy?. Eye. 2015, 29:1489-94. 10.1038\/eye.2015.134","journal-title":"Eye"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S304683","article-title":"Epidemiology of pars plana vitrectomy in the elderly: a retrospective 10-year survey of 592 cases","volume":"16","author":"Elyashiv S","year":"2021","unstructured":"Elyashiv S, Fogel Levin M, Zloto O, Neimark E, Najjar R, Moisseiev J, Vidne-Hay O. Epidemiology of pars plana vitrectomy in the elderly: a retrospective 10-year survey of 592 cases. Clin Interv Aging. 2021, 16:1007-12. 10.2147\/CIA.S304683","journal-title":"Clin Interv Aging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.5817","article-title":"Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis","volume":"141","author":"McCullough P","year":"2023","unstructured":"McCullough P, Mohite A, Virgili G, Lois N. Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol. 2023, 141:186-95. 10.1001\/jamaophthalmol.2022.5817","journal-title":"JAMA Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.300","article-title":"Adverse events after pars plana vitrectomy among medicare beneficiaries","volume":"127","author":"Stein JD","year":"2009","unstructured":"Stein JD, Zacks DN, Grossman D, Grabe H, Johnson MW, Sloan FA. Adverse events after pars plana vitrectomy among medicare beneficiaries. Arch Ophthalmol. 2009, 127:1656-63. 10.1001\/archophthalmol.2009.300","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2007.10.003","article-title":"Ophthalmologic complications of systemic disease","volume":"26","author":"Klig JE","year":"2008","unstructured":"Klig JE. Ophthalmologic complications of systemic disease. Emerg Med Clin North Am. 2008, 26:217-31, viii. 10.1016\/j.emc.2007.10.003","journal-title":"Emerg Med Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2013.03.11","article-title":"Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy","volume":"6","author":"Cheng Y","year":"2013","unstructured":"Cheng Y, Liu XH, Shen X, Zhong YS. Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy. Int J Ophthalmol. 2013, 6:316-20. 10.3980\/j.issn.2222-3959.2013.03.11","journal-title":"Int J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519872033","article-title":"Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus","volume":"47","author":"Sun X","year":"2019","unstructured":"Sun X, Zhang H, Liu J, Wang G. Serum vascular endothelial growth factor level is elevated in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Int Med Res. 2019, 47:5584-92. 10.1177\/0300060519872033","journal-title":"J Int Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147%2FOPTH.S184959","article-title":"Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy","volume":"12","author":"Sakamoto M","year":"2018","unstructured":"Sakamoto M, Hashimoto R, Yoshida I, Ubuka M, Maeno T. Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy. Clin Ophthalmol. 2018, 12:2323-9. 10.2147%2FOPTH.S184959","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/08820530902800801","article-title":"Neovascular glaucoma: etiology, diagnosis and prognosis","volume":"24","author":"Shazly TA","year":"2009","unstructured":"Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009, 24:113-21. 10.1080\/08820530902800801","journal-title":"Semin Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-016-0051-x","article-title":"Neovascular glaucoma: a review","volume":"2","author":"Rodrigues GB","year":"2016","unstructured":"Rodrigues GB, Abe RY, Zangalli C, et al.. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016, 2:26. 10.1186\/s40942-016-0051-x","journal-title":"Int J Retina Vitreous"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000431196","article-title":"Neovascular glaucoma","volume":"55","author":"Havens SJ","year":"2016","unstructured":"Havens SJ, Gulati V. Neovascular glaucoma. Dev Ophthalmol. 2016, 55:196-204. 10.1159\/000431196","journal-title":"Dev Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2021.92408","article-title":"Intraocular pressure change and sustained intraocular pressure elevation after pars plana vitrectomy","volume":"6","author":"Cabuk KS","year":"2021","unstructured":"Cabuk KS, Cekic O. Intraocular pressure change and sustained intraocular pressure elevation after pars plana vitrectomy. Beyoglu Eye J. 2021, 6:96-101. 10.14744\/bej.2021.92408","journal-title":"Beyoglu Eye J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0007-1","article-title":"Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study","volume":"15","author":"Nesaratnam N","year":"2015","unstructured":"Nesaratnam N, Sarkies N, Martin KR, Shahid H. Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study. BMC Ophthalmol. 2015, 15:17. 10.1186\/s12886-015-0007-1","journal-title":"BMC Ophthalmol"},{"key":"ref14","article-title":"Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far","volume":"17","author":"Whitmire W","year":"2011","unstructured":"Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis. 2011, 17:300-8.","journal-title":"Mol Vis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.36473","article-title":"Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration","volume":"55","author":"Kim R","year":"2007","unstructured":"Kim R. Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol. 2007, 55:413-15. 10.4103\/0301-4738.36473","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.53865","article-title":"Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma","volume":"16","author":"Ghanem AA","year":"2009","unstructured":"Ghanem AA, El-Kannishy AM, El-Wehidy AS, El-Agamy AF. Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma. Middle East Afr J Ophthalmol. 2009, 16:75-9. 10.4103\/0974-9233.53865","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee P","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998, 43:245-69. 10.1016\/s0039-6257(98)00035-6","journal-title":"Surv Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20070101-01","article-title":"Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma","volume":"38","author":"Yu XB","year":"2007","unstructured":"Yu XB, Sun XH, Dahan E, et al.. Increased levels of transforming growth factor-betal and -beta2 in the aqueous humor of patients with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007, 38:6-14. 10.3928\/15428877-20070101-01","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.11.10.2","article-title":"Aqueous humor growth factor levels and trabeculectomy outcomes in primary open-angle glaucoma patients: a 2-year prospective study","volume":"11","author":"Qian T","year":"2022","unstructured":"Qian T, Fu M, Ye L, Du J, Xu X, Zhang Z. Aqueous humor growth factor levels and trabeculectomy outcomes in primary open-angle glaucoma patients: a 2-year prospective study. Transl Vis Sci Technol. 2022, 11:2. 10.1167\/tvst.11.10.2","journal-title":"Transl Vis Sci Technol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030373","article-title":"Role of TGF-beta signaling in beta cell proliferation and function in diabetes","volume":"12","author":"Wang HL","year":"2022","unstructured":"Wang HL, Wang L, Zhao CY, Lan HY. Role of TGF-beta signaling in beta cell proliferation and function in diabetes. Biomolecules. 2022, 12:10.3390\/biom12030373","journal-title":"Biomolecules"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/291886-demographic-clinical-and-surgical-risk-factors-of-pars-plana-vitrectomy-ppv-for-neovascular-glaucoma-nvg-development-in-type-2-diabetes-mellitus-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T20:08:35Z","timestamp":1726603715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/291886-demographic-clinical-and-surgical-risk-factors-of-pars-plana-vitrectomy-ppv-for-neovascular-glaucoma-nvg-development-in-type-2-diabetes-mellitus-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.69571","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}